Tecan’s multimode readers offer staying power for biomolecular research
7 February 2013 | By kdm communications limited
Scientists at the University of Toronto, Canada, have chosen generations of Tecan microplate readers to monitor...
List view / Grid view
News
Amgen Outlines Long-Term Strategy
7 February 2013 | By Amgen
Amgen outlined the company's long-term strategy during a Business Review meeting with analysts and investors in New York City...
European submission for MEK monotherapy and BRAF/MEK combination therapy in metastatic melanoma
7 February 2013 | By GlaxoSmithKline
GSK announced submission of a Marketing Authorisation Application...
Biogen Idec to acquire full rights and control of TYSABRI® from Elan for upfront cash and contingent payments
6 February 2013 | By Biogen Idec
Biogen Idec has agreed to purchase Elan’s interest in TYSABRI...
Avacta launches application-focused Optim® 2
5 February 2013 | By kdm communications limited
Avacta Analytical has unveiled the Optim® 2 micro-volume protein analysis and characterisation instrument...
European Commission approves HUMIRA’s label update
AbbVie has announced the European Commission (EC) has approved an update to the label for HUMIRA® (adalimumab) for the treatment of adults with moderate to severe rheumatoid arthritis (RA). The update adds data demonstrating the long-term clinical benefit of HUMIRA, making it the first and only biologic medication available with…
ZALTRAP® (aflibercept) approved in the EU
5 February 2013 | By Sanofi
First and only agent to statistically significantly improve survival in combination with FOLFIRI chemotherapy after an oxaliplatin regimen...
GSK increases stake in its publicly-listed Consumer Healthcare subsidiary in India to 72.5 per cent
5 February 2013 | By GlaxoSmithKline
“We are very pleased with the outcome of this transaction..."
Gilead announces sustained virologic response rates from two Phase 3 studies of sofosbuvir for hepatitis C
4 February 2013 | By Gilead Sciences, Inc.
Topline results from two Phase 3 studies...
Once-daily Lyxumia® (lixisenatide) approved for treatment of type 2 diabetes in Europe
4 February 2013 | By Sanofi
Sanofi portfolio expands to offer first once-a-day prandial GLP-1 receptor agonist...
B&W Tek announces enhanced high resolution Raman system with smart spectrometer technology
4 February 2013 | By B&W Tek, Inc.
B&W Tek is proud to announce the i-Raman® Plus portable Raman spectrometer...
GlaxoSmithKline starts Phase III study to test combined BRAF/MEK inhibition in patients with BRAF positive melanoma following surgery
1 February 2013 | By GlaxoSmithKline
GSK announced the start of COMBI-AD...
Obinutuzumab (GA101) significantly improved progression-free survival in people with chronic lymphocytic leukemia (CLL)
31 January 2013 | By Roche
Positive results from stage 1 of CLL11...
BASF completes acquisition of Pronova BioPharma
31 January 2013 | By BASF
BASF has completed the acquisition of Pronova BioPharma ASA, Lysaker, Norway...
Novo Nordisk increased operating profit by 32% in 2012
31 January 2013 | By Novo Nordisk
Sales growth of 18% driven by Victoza®, NovoRapid® and Levemir®...
